deltatrials
Terminated OBSERVATIONAL NCT03063905

The Effects of Opioid Taper on Opioid-Induced Hyperalgesia

Sponsor: Georgetown University

Interventions Buprenorphine
Updated 7 times since 2017 Last updated: Mar 19, 2018 Started: Jan 31, 2017 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

funding expired

Listed as NCT03063905, this observational or N/A phase trial focuses on Buprenorphine and Pain and remains terminated or withdrawn. Sponsored by Georgetown University, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Mar 2017 – ~Feb 2018 · 11 months · monthly snapshotRecruiting~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshotRecruiting~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated

  5. Apr 2018 — Jun 2018 [monthly]

    Terminated

    Status: RecruitingTerminated · Phase: NANone

Show 2 earlier versions
  1. Feb 2018 — Apr 2018 [monthly]

    Recruiting NA

  2. Mar 2017 — Feb 2018 [monthly]

    Recruiting NA

    First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Georgetown University
  • National Institute on Drug Abuse (NIDA)
Data source: Georgetown University

For direct contact, visit the study record on ClinicalTrials.gov .